As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk
Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists Key takeaways: Washington has…
RELATED ARTICLES
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG -
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
